T-cell activation by recombinant immunoreceptors:: Impact of the intracellular signalling domain on the stability of receptor expression and antigen-specific activation of grafted T cells

被引:44
作者
Heuser, C
Hombach, A
Lösch, C
Manista, K
Abken, H
机构
[1] Univ Cologne, Innere Med Klin 1, Lab Tumor Genet, D-50924 Cologne, Germany
[2] Univ Cologne, Zentrum Mol Med Koln, D-50924 Cologne, Germany
关键词
chimeric T-cell receptor; Fc epsilon RI gamma-chain; CD3 zeta chain; immunotherapy;
D O I
10.1038/sj.gt.3302023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant immunoreceptors are modularily composed of extracellular antigen binding and intracellular signalling domains that are preferentially derived from CD3zeta or FcepsilonRIgamma. The impact of the signalling domain on the stability of immuoreceptor expression and function is not completely understood. To address this issue, we generated and expressed a panel of recombinant zeta- and gamma-chain immunoreceptors, respectively, in human peripheral blood T cells. The expression level of zeta-chain immunoreceptors in human T cells is significantly lower than those of the homologous gamma-chain receptors. Low zeta-chain receptor expression in peripheral T cells is because of the intracellular signalling domain and independent of the FceRIg or CD3z transmembrane region. Expression of both receptors decreases upon prolonged cultivation. Shortly after receptor engraftment, target cell lysis and induction of IFN-gamma secretion are mediated with similar efficiency by zeta- and gamma-chain immunoreceptors. Upon prolonged propagation, however, T-cell activation mediated by zeta-chain immunoreceptors is more efficient than by gamma-chain receptors, indicating that the initial high expression level of gamma-chain immunoreceptors compensates its lower activation capacity. Consequently, gamma-chain immunoreceptors exhibit a higher threshold value for specific activation and are more pronouncedly inhibited by soluble ligand antigen compared to the homologous zeta-chain receptor. These findings have substantial consequences for the design of recombinant immunoreceptors for use in adoptive immunotherapy.
引用
收藏
页码:1408 / 1419
页数:12
相关论文
共 32 条
[1]   Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells? [J].
Abken, H ;
Hombach, A ;
Reinhold, U ;
Ferrone, S .
IMMUNOLOGY TODAY, 1998, 19 (01) :2-5
[2]   SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS [J].
ESHHAR, Z ;
WAKS, T ;
GROSS, G ;
SCHINDLER, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :720-724
[3]  
Frank S J, 1991, Semin Immunol, V3, P299
[4]   Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors [J].
Haynes, NM ;
Trapani, JA ;
Teng, MWL ;
Jackson, JT ;
Cerruti, L ;
Jane, SM ;
Kershaw, MH ;
Smyth, MJ ;
Darcy, PK .
BLOOD, 2002, 100 (09) :3155-3163
[5]   Redirecting mouse CTL against colon carcinoma:: Superior signaling efficacy of single-chain variable domain chimeras containing TCR-ζ vs FcεRI-γ [J].
Haynes, NM ;
Snook, MB ;
Trapani, JA ;
Cerruti, L ;
Jane, SM ;
Smyth, MJ ;
Darcy, PK .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :182-187
[6]   T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope [J].
Hombach, A ;
Heuser, C ;
Sircar, R ;
Tillmann, T ;
Diehl, V ;
Kruis, W ;
Pohl, C ;
Abken, H .
GASTROENTEROLOGY, 1997, 113 (04) :1163-1170
[7]  
Hombach A, 2001, CANCER RES, V61, P1976
[8]   CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion [J].
Hombach, A ;
Heuser, C ;
Marquardt, T ;
Wieczarkowiecz, A ;
Groneck, V ;
Pohl, C ;
Abken, H .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :1090-1096
[9]   Tumor-specific T cell activation by recombinant immunoreceptors:: CD3ζ signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can ge integrated into one combined CD28/CD3ζ signaling receptor molecule [J].
Hombach, A ;
Wieczarkowiecz, A ;
Marquardt, T ;
Heuser, C ;
Usai, L ;
Pohl, C ;
Seliger, B ;
Abken, H .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6123-6131
[10]   T cell activation by recombinant FcεRI γ-chain immune receptors:: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition [J].
Hombach, A ;
Heuser, C ;
Gerken, M ;
Fischer, B ;
Lewalter, K ;
Diehl, V ;
Pohl, C ;
Abken, H .
GENE THERAPY, 2000, 7 (12) :1067-1075